Serina Therapeutics, Inc. (SER)

Serina Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.19	7.62	0.53	0.31
Short-Term Investments	-	-	-	1
Cash & Short-Term Investments	3.19	7.62	0.53	1.31
Cash Growth	-57.99%	1331.41%	-59.41%	-
Receivables	0.01	-	-	0
Prepaid Expenses	2.22	-	0.02	0.02
Total Current Assets	5.42	7.62	0.55	1.33
Property, Plant & Equipment	1.12	1.35	0.31	0.51
Total Assets	7.44	8.97	0.86	1.84
Accounts Payable	1.7	0.58	0.14	0.15
Accrued Expenses	1.16	0.57	0.01	0.01
Current Portion of Leases	-	0.25	0.13	0.21
Current Unearned Revenue	-	-	0.15	-
Other Current Liabilities	0.2	0.01	0.01	0
Total Current Liabilities	13.51	1.41	0.44	0.37
Long-Term Debt	0.69	2.98	1.62	-
Long-Term Leases	0.31	0.46	0.06	0.19
Other Long-Term Liabilities	6.74	-	1.08	0.95
Total Liabilities	21.26	4.86	3.19	1.51
Common Stock	0	0.02	0.02	0.02
Additional Paid-In Capital	8	0.86	0.65	0.64
Retained Earnings	-21.78	-33.18	-38.45	-35.76
Total Common Equity	-13.77	-32.29	-37.78	-35.11
Shareholders' Equity	-13.83	4.11	-2.34	0.33
Total Liabilities & Equity	7.44	8.97	0.86	1.84
Total Debt	11.47	3.69	1.81	0.4
Net Cash (Debt)	-8.28	3.92	-1.28	0.91
Net Cash Per Share	-1.45	0.98	-0.60	0.43
Filing Date Shares Outstanding	8.89	8.79	2.22	2.14
Total Common Shares Outstanding	-	2.47	2.22	2.14
Working Capital	-8.09	6.21	0.11	0.96
Book Value Per Share	-	-13.09	-17.03	-16.37
Tangible Book Value	-14.28	-32.29	-37.78	-35.11
Tangible Book Value Per Share	-	-13.09	-17.03	-16.37
Machinery	-	0.87	0.38	0.37

Source: S&P Capital IQ. Standard template. Financial Sources.